SavedAdd your journal

Journals / IUFS Journal of Biology / 2009 / Cilt: 68 - Sayı: 2

Nitric oxide response to acute exercise in patients with coronary artery disease

Ayşem KAYA
Serdar KÜÇÜKOĞLU
Huriye BALCI
Alev Arat ÖZKAN
Zerrin YİĞİT
Tevfik GÜRMEN
Okay ABACI
Özge KÖNER
Pages
85–91
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Basal serum NOx levels of both diabetics (24$pm$8.4μmol/L,p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nitric oxide (NO) has been identified as a vasodilatory substance released from the endothelium which decreasesin the presence of atherosclerosis.
📊
Key Findings & Data:Group A (n=50) consisted of nondiabetic CADpatients,group B (n=20) consisting of diabetic, CAD patients and group C (n=20) of healthy controls.
💡
Conclusion & Impact:Basal serum NOx levels of both diabetics (24$pm$8.4μmol/L,p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nitric oxide (NO) has been identified as a vasodilatory substance released from the endothelium which decreasesin the presence of atherosclerosis. This study aimed to evaluate the systemic NO response to acute exercise inuntrained diabetic and nondiabetic patients with atherosclerotic coronary artery disease (CAD). This is aprospective, clinical study consisting of three groups. Group A (n=50) consisted of nondiabetic CADpatients,group B (n=20) consisting of diabetic, CAD patients and group C (n=20) of healthy controls. Allpatients underwent a standard symptom limited treadmill exercise test according to the modified Bruce protocolafter 24 hours low nitrite/ nitrate diet. End products of nitric oxide metabolism (NOx) were determined as thehalf life of NO is very short. Basal serum NOx levels of both diabetics (24$pm$8.4μmol/L,p

🔖

Cite This Article

KAYA, A., KÜÇÜKOĞLU, S., BALCI, H., ÖZKAN, A. A., YİĞİT, Z., GÜRMEN, T., ABACI, O., KÖNER, Ö. (2022). Nitric oxide response to acute exercise in patients with coronary artery disease. IUFS Journal of Biology, Cilt: 68 - Sayı: 2, 85–91. https://ajindex.com/articles/544059

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Akinola A.B, Land J.M, Mathias CJ, Giovannoni G, Magnifico F, Puvirajasingham S, Smith G.D, Watson L. (1999) Contribution of nitric oxide to exercise induced hypotension in human sympathetic denervation. Clinical Autonomic Research, 9: 263-269.
  2. Arvola P, Wu X, Kaehoenen M, Makynen H, Riutta A, Mucha I, Solakivi T, Kainulainen H, Porsti I. (1999) Exercise enhances vasorelaxation in experimental obesity associated hypertension. Cardiovascular Research, 43: 992-1002.
  3. Awolesi M.A, Sessa W.C, Sumpio B.E. (1995) Cyclic strain upregulates nitricoxide synthase in cultured bovine aortic endothelial cells. The Journal of Clinical Investigation, 96: 1449-1454.
  4. Busse R, Fleming I. (1996) Endothelial dysfunction in atherosclerosis. Journal of Vascular Research, 33: 181-94.
  5. Canty J.M, Schwartz J.S. (1994) Nitricoxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation, 89: 375-384.
  6. Cardillo C, Kilcoyne CM, Quyyumi A.A, Cannon R.O, Panza J.A. (1998) Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation, 97: 851-856.
  7. Forte P, Copland M, Smith L.M, Milne E, Sutherland J, Benjamin N. (1997) Basal nitricoxide synthesis in essential hypertension. Lancet, 349: 837-842.
  8. Gordon M.B, Jain R, Beckman J.A, Creager M.A. (2002) The contribution of nitric oxide to exercise hyperemia in the human forearm. Vascular Medicine (London) England, 7: 163-168.
  9. Heitzer T, Just H, Munzel T. (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation, 94: 6-9.
  10. Jungersten L, Edlund A, Petersson A.S, Wennmalm A. (1996) Plasma nitrate as an index of nitricoxide formation in man: analyses of kinetics and confounding factors. Clinical Physiology, Oxford England, 16: 369-379. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. (1998) The New England Journal of Medicine, 339: 1349-1357.
  11. Liyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, Mikami H, Ogihara T. (1996) Impaired endothelial function with essential hypertension assessed by ultrasonography. American Heart Journal, 132: 779-782.
  12. Moncada S, Palmer R.M.J, Higgis E.A. (1991) Nitric oxide: physiology, pathophysiology and pharma